ArticleThe British journal of dermatology2026

Targeting noncanonical nuclear factor kappa B signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha.

Kirsty Hodgson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.